E97-20295-54529
3 vaccinations
4 coded responses
26 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 21-25
- ZIP prefix
- 405 / KY
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Registered in v-safe
-
2021-02-19
Dose 1 — Pfizer-BioNTech
- 2021-02-19
-
2021-02-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Abdominal painAdult check-in
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
-
2021-03-12
Dose 2 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-06-11
Survey response — 3 months, dose 2MedDRA: Cough, Eye pruritus, Hypersensitivity, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative, Sinus disorder, Sneezing — Feeling: GoodFree text: Cold or allergy -like symptoms: sneezing, itchy eyes, stuffy nose and sinuses followed by sore throat and mild cough. Tested negative for COVID-19 twice while symptomatic.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-10
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Oropharyngeal pain, Productive cough, Sinus congestion — Feeling: GoodFree text: Experienced cold-like symptoms for about a week: stuffy sinuses and sore throat, followed by a wet cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-14
Survey response — 12 months, dose 2MedDRA: Chills, Cough, Fatigue, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: For about a week after testing positive for COVID-19, I experienced fever, chills, and fatigue. A minor cough continued for about another week.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Dose 3 — Pfizer-BioNTech
-
2022-04-23
Survey response — day 21, dose 3MedDRA: Cough, Fatigue, Influenza, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I experienced a bout of cold/flu symptoms with fever, fatigue, and cough. Lasted about 1 week, since recovered except for lingering cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech | |
| 3 | 2022-03-27 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Cold or allergy -like symptoms: sneezing, itchy eyes, stuffy nose and sinuses followed by sore throat and mild cough. Tested negative for COVID-19 twice while symptomatic.
Release 9 — 6 months, dose 2
Symptoms: Experienced cold-like symptoms for about a week: stuffy sinuses and sore throat, followed by a wet cough.
Release 11 — 12 months, dose 2
Symptoms: For about a week after testing positive for COVID-19, I experienced fever, chills, and fatigue. A minor cough continued for about another week.
Release 11 — day 21, dose 3
Symptoms: I experienced a bout of cold/flu symptoms with fever, fatigue, and cough. Lasted about 1 week, since recovered except for lingering cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Eye pruritus | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sinus disorder | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release